- Home
- AWX vs VYNE Comparison
AWX vs VYNE Comparison
Compare AWX & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AWX
- VYNE
- Stock Information
- Founded
- AWX 1998
- VYNE 2003
- Country
- AWX United States
- VYNE United States
- Employees
- AWX N/A
- VYNE N/A
- Industry
- AWX Environmental Services
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- AWX Utilities
- VYNE Health Care
- Exchange
- AWX Nasdaq
- VYNE Nasdaq
- Market Cap
- AWX 9.7M
- VYNE 7.9M
- IPO Year
- AWX 1998
- VYNE 2018
- Fundamental
- Price
- AWX $2.52
- VYNE $0.31
- Analyst Decision
- AWX
- VYNE Buy
- Analyst Count
- AWX 0
- VYNE 2
- Target Price
- AWX N/A
- VYNE $8.00
- AVG Volume (30 Days)
- AWX 2.7K
- VYNE 1.7M
- Earning Date
- AWX 11-07-2025
- VYNE 11-06-2025
- Dividend Yield
- AWX N/A
- VYNE N/A
- EPS Growth
- AWX 306.94
- VYNE N/A
- EPS
- AWX 0.03
- VYNE N/A
- Revenue
- AWX $78,200,000.00
- VYNE $476,000.00
- Revenue This Year
- AWX N/A
- VYNE N/A
- Revenue Next Year
- AWX N/A
- VYNE N/A
- P/E Ratio
- AWX $82.63
- VYNE N/A
- Revenue Growth
- AWX N/A
- VYNE N/A
- 52 Week Low
- AWX $2.10
- VYNE $0.28
- 52 Week High
- AWX $3.99
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- AWX 53.15
- VYNE 32.10
- Support Level
- AWX $2.46
- VYNE $0.30
- Resistance Level
- AWX $2.49
- VYNE $0.33
- Average True Range (ATR)
- AWX 0.04
- VYNE 0.02
- MACD
- AWX 0.01
- VYNE 0.02
- Stochastic Oscillator
- AWX 91.15
- VYNE 39.66
About AWX Avalon Holdings Corporation
Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.